Literature DB >> 21349086

Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection.

Simon Fillatreau1.   

Abstract

Infections by intracellular bacterial pathogens remain a major cause of human diseases worldwide. Despite intensive efforts, the development of effective vaccines or immunotherapies against these diseases has largely remained unsuccessful, asking for the exploration of new aspects of the host response to these pathogens. Genetic studies have demonstrated beyond doubt that cell-mediated mechanisms of host defense involving innate immunity and T cells are of crucial importance for the control of these diseases. By contrast, the role of B cells during intracellular bacterial infection has so far received little attention besides their role as antibody-producing cells. However, the general knowledge of B-cell immunology and in particular of their antibody-independent functions has greatly increased during the last years. Recently, it was found in a model of Salmonella typhimurium infection that Toll-like receptor triggering on B cells resulted through interleukin-10 secretion in a marked suppression of innate defense mechanisms ultimately leading to uncontrolled growth of the bacteria and earlier death from the disease during both primary and secondary infections. This article reviews the protective and deleterious roles of B cells during intracellular bacterial infections and discusses how manipulating their antibody-independent functions may be a powerful means to therapeutically improve host resistance against these diseases.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349086     DOI: 10.1111/j.1600-065X.2010.00991.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  20 in total

1.  Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice.

Authors:  Damian Maseda; Kathleen M Candando; Susan H Smith; Ioannis Kalampokis; Casey T Weaver; Scott E Plevy; Jonathan C Poe; Thomas F Tedder
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

Review 2.  The role of regulatory B cells in digestive system diseases.

Authors:  Zhenyu Zhou; Lei Gong; Xiaoyun Wang; Zhen Hu; Gaojue Wu; Xuejun Tang; Xiaobin Peng; Shuan Tang; Miao Meng; Hui Feng
Journal:  Inflamm Res       Date:  2016-11-22       Impact factor: 4.575

Review 3.  Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.

Authors:  Charles E Egwuagu; Cheng-Rong Yu
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

Review 4.  Subversion of host recognition and defense systems by Francisella spp.

Authors:  Crystal L Jones; Brooke A Napier; Timothy R Sampson; Anna C Llewellyn; Max R Schroeder; David S Weiss
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 5.  B10 cell regulation of health and disease.

Authors:  Kathleen M Candando; Jacquelyn M Lykken; Thomas F Tedder
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

6.  The regulatory capacity of B cells directs the aggressiveness of CLL.

Authors:  Audrey Mohr; Marie Cumin; Cristina Bagacean; Pierre Pochard; Christelle Le Dantec; Sophie Hillion; Yves Renaudineau; Christian Berthou; Adrian Tempescul; Hussam Saad; Jacques-Olivier Pers; Anne Bordron; Christophe Jamin
Journal:  Oncoimmunology       Date:  2018-12-12       Impact factor: 8.110

Review 7.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

8.  Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells.

Authors:  Ruddy Montandon; Sarantis Korniotis; Esther Layseca-Espinosa; Christophe Gras; Jérôme Mégret; Sophie Ezine; Michel Dy; Flora Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

9.  B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis.

Authors:  Alan Bénard; Imme Sakwa; Pablo Schierloh; André Colom; Ingrid Mercier; Ludovic Tailleux; Luc Jouneau; Pierre Boudinot; Talal Al-Saati; Roland Lang; Jan Rehwinkel; Andre G Loxton; Stefan H E Kaufmann; Véronique Anton-Leberre; Anne O'Garra; Maria Del Carmen Sasiain; Brigitte Gicquel; Simon Fillatreau; Olivier Neyrolles; Denis Hudrisier
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

10.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.

Authors:  Ping Shen; Toralf Roch; Vicky Lampropoulou; Richard A O'Connor; Ulrik Stervbo; Ellen Hilgenberg; Stefanie Ries; Van Duc Dang; Yarúa Jaimes; Capucine Daridon; Rui Li; Luc Jouneau; Pierre Boudinot; Siska Wilantri; Imme Sakwa; Yusei Miyazaki; Melanie D Leech; Rhoanne C McPherson; Stefan Wirtz; Markus Neurath; Kai Hoehlig; Edgar Meinl; Andreas Grützkau; Joachim R Grün; Katharina Horn; Anja A Kühl; Thomas Dörner; Amit Bar-Or; Stefan H E Kaufmann; Stephen M Anderton; Simon Fillatreau
Journal:  Nature       Date:  2014-02-23       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.